Drug: EPIRUBICIN Injury: Exposure during pregnancy Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126385471 | EPIRUBICIN | Exposure during pregnancy | MERCK | 0.00 YR | F | 2 KG | 20160809 | CH |
126409201 | EPIRUBICIN | Exposure during pregnancy | GLAXOSMITHKLINE | 36.77 YR | F | 69 KG | 20160810 | CH |
126481232 | EPIRUBICIN | Exposure during pregnancy | SANDOZ | 36.77 YR | F | 69 KG | 20160815 | CH |
126546901 | EPIRUBICIN | Exposure during pregnancy | HELSINN HEALTHCARE | 36.77 YR | F | 69 KG | 20160816 | CH |
126611621 | Epirubicin | Exposure during pregnancy | TEVA | 0.00 YR | F | 2 KG | 20160817 | CH |
Total Records: 5 Number of Pages: 1